{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:30:06Z","timestamp":1782138606957,"version":"3.54.5"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The utilization of extracorporeal renal replacement therapy (RRT), including continuous renal replacement therapy (CRRT) and hemodialysis (HD), beyond the treatment of volume overload and acute kidney injury (AKI) has witnessed a significant shift, demonstrating the potential to improve patient outcomes for a range of diseases. This comprehensive review explores the non-kidney applications for RRT platforms in critically ill children, focusing on diverse clinical scenarios such as sepsis, inborn errors of metabolism, liver failure, drug overdose, tumor lysis syndrome, and rhabdomyolysis. In the context of sepsis and septic shock, RRT not only facilitates fluid, electrolyte, and acid\/base homeostasis, but may offer benefits in cytokine regulation, endotoxin clearance, and immunomodulation which may improve multi-organ dysfunction as well as hemodynamic challenges posed by this life-threatening condition. RRT modalities also have an important role in caring for children with inborn errors of metabolism, liver failure, and tumor lysis syndrome as they can control metabolic derangements with the efficient clearance of endogenous toxins in affected children. In cases of drug overdose, RRT is a crucial tool for rapid extracorporeal clearance of exogenous toxins, mitigating potential organ damage. The intricate interplay between liver failure and kidney function is examined, elucidating the role of RRT and plasma exchange in maintaining fluid and electrolyte balance when hepatic dysfunction complicates the clinical picture. Furthermore, RRT and HD are explored in the context of rhabdomyolysis, highlighting their utility in addressing AKI secondary to traumatic events and crush syndrome.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1007\/s00467-024-06533-z","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T02:01:55Z","timestamp":1728352915000},"page":"923-932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extracorporeal pediatric renal replacement therapy: diversifying application beyond kidney failure"],"prefix":"10.1007","volume":"40","author":[{"given":"Rahul","family":"Chanchlani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Askenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benan","family":"Bayrakci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-5570","authenticated-orcid":false,"given":"Akash","family":"Deep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara M.","family":"Neumayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"6533_CR1","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1097\/PCC.0b013e31824fbd76","volume":"13","author":"GM Fleming","year":"2012","unstructured":"Fleming GM, Walters S, Goldstein SL, Alexander SR, Baum MA, Blowey DL, Bunchman TE, Chua AN, Fletcher SA, Flores FX, Fortenberry JD, Hackbarth R, McBryde K, Somers MJ, Symons JM, Brophy PD (2012) Nonrenal indications for continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group. Pediatr Crit Care Med 13:e299-304","journal-title":"Pediatr Crit Care Med"},{"key":"6533_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000328961","volume":"173","author":"M Thomas","year":"2011","unstructured":"Thomas M, Moriyama K, Ledebo I (2011) AN69: evolution of the world\u2019s first high permeability membrane. Contrib Nephrol 173:119\u2013129","journal-title":"Contrib Nephrol"},{"issue":"Suppl 3","key":"6533_CR3","first-page":"1","volume":"47","author":"C Monard","year":"2019","unstructured":"Monard C, Rimmel\u00e9 T, Ronco C (2019) Extracorporeal blood purification therapies for sepsis. Blood Purif 47(Suppl 3):1\u201314","journal-title":"Blood Purif"},{"key":"6533_CR4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.605212","volume":"12","author":"A Stasi","year":"2021","unstructured":"Stasi A, Franzin R, Divella C, Sallustio F, Curci C, Picerno A, Pontrelli P, Staffieri F, Lacitignola L, Crovace A, Cantaluppi V, Medica D, Ronco C, de Cal M, Lorenzin A, Zanella M, Pertosa GB, Stallone G, Gesualdo L, Castellano G (2021) PMMA-based continuous hemofiltration modulated complement activation and renal dysfunction in LPS-induced acute kidney injury. Front Immunol 12:605212","journal-title":"Front Immunol"},{"key":"6533_CR5","first-page":"1","volume":"53","author":"A Spasiano","year":"2023","unstructured":"Spasiano A, De Luca G, Bartoli G, Dello Strologo A, Arena M, Grandaliano G (2024) COVID-19: the dysregulated response to infection - why consider polymethylmethacrylate membrane in hemodialysis patients? Blood Purif 53:373\u2013378","journal-title":"Blood Purif"},{"key":"6533_CR6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4266\/acc.2022.00192","volume":"37","author":"K Kinjoh","year":"2022","unstructured":"Kinjoh K, Nagamura R, Sakuda Y, Yamauchi S, Takushi H, Iraha T, Idomari K (2022) Clinical efficacy of blood purification using a polymethylmethacrylate hemofilter for the treatment of severe acute pancreatitis. Acute Crit Care 37:398\u2013406","journal-title":"Acute Crit Care"},{"key":"6533_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13054-023-04555-x","volume":"27","author":"G Wang","year":"2023","unstructured":"Wang G, He Y, Guo Q, Zhao Y, He J, Chen Y, Chen W, Zhou Y, Peng Z, Deng K, Guan J, Xie W, Chang P, Liu Z (2023) Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis. Crit Care 27:275","journal-title":"Crit Care"},{"key":"6533_CR8","volume":"10","author":"PH Phan","year":"2022","unstructured":"Phan PH, Nguyen DT, Dao NH, Nguyen HTT, Vu AV, Hoang ST, Nguyen LV, Cao TV, Tran DM (2022) Case report: successful treatment of a child with COVID-19 reinfection-induced fulminant myocarditis by cytokine-adsorbing oXiris\u00ae hemofilter continuous veno-venous hemofiltration and extracorporeal membrane oxygenation. Front Pediatr 10:946547","journal-title":"Front Pediatr"},{"key":"6533_CR9","first-page":"3373289","volume":"2022","author":"P Lalwani","year":"2022","unstructured":"Lalwani P, Baskaran S, Uribe DA, Ramaiah A, Saqib A, ElMesserey M, Fathi EM, Tabata Y, Fink C, Pallavidino M (2022) A case of COVID-19-associated pediatric multisystem inflammatory syndrome in shock managed by cytokine filtration. Case Rep Pediatr 2022:3373289","journal-title":"Case Rep Pediatr"},{"key":"6533_CR10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000530147","volume":"52","author":"L Morin","year":"2023","unstructured":"Morin L, Charbel R, Cousin VL, Marais C, Claude C, Barreault S, Durand P, Miatello J, Tissi\u00e8res P (2023) Blood purification with oXiris\u00a9 in critically ill children with vasoplegic shock. Blood Purif 52:541\u2013548","journal-title":"Blood Purif"},{"key":"6533_CR11","first-page":"2000781","volume":"2023","author":"J Ying","year":"2023","unstructured":"Ying J, Cai X, Lu G, Chen W (2023) The use of membranes (ST-100, oXiris, and M60) for continuous renal replacement therapy in a child with sepsis. Case Rep Crit Care 2023:2000781","journal-title":"Case Rep Crit Care"},{"key":"6533_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","volume":"27","author":"S Becker","year":"2023","unstructured":"Becker S, Lang H, Vollmer Barbosa C, Tian Z, Melk A, Schmidt BMW (2023) Efficacy of CytoSorb\u00ae: a systematic review and meta-analysis. Crit Care 27:215","journal-title":"Crit Care"},{"key":"6533_CR13","doi-asserted-by":"crossref","first-page":"1259384","DOI":"10.3389\/fped.2023.1259384","volume":"11","author":"G Bottari","year":"2023","unstructured":"Bottari G, Guzzo I, Cappoli A, Labbadia R, Perdichizzi S, Serpe C, Creteur J, Cecchetti C, Taccone FS (2023) Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study. Front Pediatr 11:1259384","journal-title":"Front Pediatr"},{"key":"6533_CR14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ekir.2020.12.010","volume":"6","author":"SL Goldstein","year":"2021","unstructured":"Goldstein SL, Askenazi DJ, Basu RK, Selewski DT, Paden ML, Krallman KA, Kirby CL, Mottes TA, Terrell T, Humes HD (2021) Use of the selective cytopheretic device in critically ill children. Kidney Int Rep 6:775\u2013784","journal-title":"Kidney Int Rep"},{"key":"6533_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132482","volume":"10","author":"JA Tumlin","year":"2015","unstructured":"Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD (2015) A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury. PLoS One 10:e0132482","journal-title":"PLoS ONE"},{"key":"6533_CR16","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000662","volume":"4","author":"SA Chitty","year":"2022","unstructured":"Chitty SA, Mobbs S, Rifkin BS, Stogner SW, Lewis MS, Betancourt J, DellaVolpe J, Abouzahr F, Wilhelm AM, Szerlip HM, Parikh A, Gaeta RM, Rivera I, Park C, Levi B, Anesi GL, Alcover KC, Arnold TB, Howard JT, Sharma K, Pratt KP, Stewart IJ, Chung KK (2022) A multicenter evaluation of the Seraph 100 Microbind Affinity Blood Filter for the treatment of severe COVID-19. Crit Care Explor 4:e0662","journal-title":"Crit Care Explor"},{"key":"6533_CR17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ndt\/gfab347","volume":"37","author":"JJ Schmidt","year":"2022","unstructured":"Schmidt JJ, Borchina DN, Van\u2019t Klooster M, Bulhan-Soki K, Okioma R, Herbst L, Rodr\u00edguez DS, Premu\u017ei\u0107 V, B\u00fcttner S, Bader B, Serednicki W, Zasada E, Schmitz M, Quabach RA, Hrincheva M, F\u00fchner T, Kielstein JT (2022) Interim analysis of the COSA (COVID-19 patients treated with the Seraph\u00ae 100 Microbind\u00ae Affinity filter) registry. Nephrol Dial Transplant 37:673\u2013680","journal-title":"Nephrol Dial Transplant"},{"key":"6533_CR18","doi-asserted-by":"crossref","first-page":"e2670","DOI":"10.1093\/milmed\/usad063","volume":"188","author":"S Stoffel","year":"2023","unstructured":"Stoffel S, Boster J, Jarrett Z, Rosas M, Kalra A, Nugyen M, Morris M, Walter R (2023) Single-center experience with the Seraph-100\u00ae Microbind\u00ae Affinity Blood Filter in patients with SARS-CoV-2 infection and septic shock at a military treatment facility. Mil Med 188:e2670\u2013e2674","journal-title":"Mil Med"},{"key":"6533_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000527290","volume":"13","author":"KA Merrill","year":"2023","unstructured":"Merrill KA, Krallman KA, Loeb D, Standage SW, Mattoon D, Shan D, Goldstein SL, Schuh MP (2023) First-time use of the Seraph(\u00ae) 100 Microbind(\u00ae) Affinity Blood Filter in an adolescent patient with severe COVID-19 disease: a case report. Case Rep Nephrol Dial 13:1\u20136","journal-title":"Case Rep Nephrol Dial"},{"key":"6533_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00467-023-06097-4","volume":"39","author":"DS Li","year":"2024","unstructured":"Li DS, Burke TM, Smith JM, Reed RC, Okamura DM, Menon S (2024) Use of the Seraph\u00ae 100 Microbind\u00ae Affinity Blood Filter in an adolescent patient with disseminated adenoviral disease. Pediatr Nephrol 39:331\u2013335","journal-title":"Pediatr Nephrol"},{"key":"6533_CR21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-0039-1683991","volume":"8","author":"AF Yetimakman","year":"2019","unstructured":"Yetimakman AF, Kesici S, Tanyildiz M, Bayrakci B (2019) Continuous renal replacement therapy for treatment of severe attacks of inborn errors of metabolism. J Pediatr Intensive Care 8:164\u2013169","journal-title":"J Pediatr Intensive Care"},{"key":"6533_CR22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pedneo.2017.04.004","volume":"59","author":"F Aygun","year":"2018","unstructured":"Aygun F, Aygun D, Erbek Alp F, Zubarioglu T, Zeybek C, Cam H (2018) The impact of continuous renal replacement therapy for metabolic disorders in infants. Pediatr Neonatol 59:85\u201390","journal-title":"Pediatr Neonatol"},{"key":"6533_CR23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00467-021-05329-9","volume":"37","author":"FT Eminoglu","year":"2022","unstructured":"Eminoglu FT, Oncul U, Kahveci F, Okulu E, Kraja E, Kose E, Kendirli T (2022) Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders. Pediatr Nephrol 37:1387\u20131397","journal-title":"Pediatr Nephrol"},{"key":"6533_CR24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41581-020-0267-8","volume":"16","author":"R Raina","year":"2020","unstructured":"Raina R, Bedoyan JK, Lichter-Konecki U, Jouvet P, Picca S, Mew NA, Machado MC, Chakraborty R, Vemuganti M, Grewal MK, Bunchman T, Sethi SK, Krishnappa V, McCulloch M, Alhasan K, Bagga A, Basu RK, Schaefer F, Filler G, Warady BA (2020) Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy. Nat Rev Nephrol 16:471\u2013482","journal-title":"Nat Rev Nephrol"},{"key":"6533_CR25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2022.03.043","volume":"246","author":"EG Ames","year":"2022","unstructured":"Ames EG, Powell C, Engen RM, Weaver DJ Jr, Mansuri A, Rheault MN, Sanderson K, Lichter-Konecki U, Daga A, Burrage LC, Ahmad A, Wenderfer SE, Luckritz KE (2022) Multisite retrospective review of outcomes in renal replacement therapy for neonates with inborn errors of metabolism. J Pediatr 246:116-122.e111","journal-title":"J Pediatr"},{"key":"6533_CR26","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00467-020-04533-3","volume":"35","author":"EG Ames","year":"2020","unstructured":"Ames EG, Luckritz KE, Ahmad A (2020) A retrospective review of outcomes in the treatment of hyperammonemia with renal replacement therapy due to inborn errors of metabolism. Pediatr Nephrol 35:1761\u20131769","journal-title":"Pediatr Nephrol"},{"key":"6533_CR27","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2215\/CJN.01320216","volume":"11","author":"S Gupta","year":"2016","unstructured":"Gupta S, Fenves AZ, Hootkins R (2016) The role of RRT in hyperammonemic patients. Clin J Am Soc Nephrol 11:1872\u20131878","journal-title":"Clin J Am Soc Nephrol"},{"key":"6533_CR28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s004670100702","volume":"16","author":"S Picca","year":"2001","unstructured":"Picca S, Dionisi-Vici C, Abeni D, Pastore A, Rizzo C, Orzalesi M, Sabetta G, Rizzoni G, Bartuli A (2001) Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 16:862\u2013867","journal-title":"Pediatr Nephrol"},{"key":"6533_CR29","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM198406073102304","volume":"310","author":"M Msall","year":"1984","unstructured":"Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED (1984) Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 310:1500\u20131505","journal-title":"N Engl J Med"},{"key":"6533_CR30","first-page":"1","volume":"14","author":"ML Batshaw","year":"1984","unstructured":"Batshaw ML (1984) Hyperammonemia. Curr Probl Pediatr 14:1\u201369","journal-title":"Curr Probl Pediatr"},{"key":"6533_CR31","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/ped.12101","volume":"55","author":"M Kaneko","year":"2013","unstructured":"Kaneko M, Ogasawara K, Go H, Imamura T, Momoi N, Hosoya M (2013) Continuous hemodialysis therapy for an extremely low-birthweight infant with hyperammonemia. Pediatr Int 55:656\u2013658","journal-title":"Pediatr Int"},{"key":"6533_CR32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ndt\/5.3.192","volume":"5","author":"A Davenport","year":"1990","unstructured":"Davenport A, Will EJ, Davison AM (1990) Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant 5:192\u2013198","journal-title":"Nephrol Dial Transplant"},{"key":"6533_CR33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00467-014-2945-x","volume":"30","author":"S Picca","year":"2015","unstructured":"Picca S, Dionisi-Vici C, Bartuli A, De Palo T, Papadia F, Montini G, Materassi M, Donati MA, Verrina E, Schiaffino MC, Pecoraro C, Iaccarino E, Vidal E, Burlina A, Emma F (2015) Short-term survival of hyperammonemic neonates treated with dialysis. Pediatr Nephrol 30:839\u2013847","journal-title":"Pediatr Nephrol"},{"key":"6533_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3345\/kjp.2018.07143","volume":"62","author":"H Cho","year":"2019","unstructured":"Cho H (2019) Renal replacement therapy in neonates with an inborn error of metabolism. Korean J Pediatr 62:43\u201347","journal-title":"Korean J Pediatr"},{"key":"6533_CR35","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s00467-007-0436-z","volume":"22","author":"TE Bunchman","year":"2007","unstructured":"Bunchman TE, Barletta GM, Winters JW, Gardner JJ, Crumb TL, McBryde KD (2007) Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration. Pediatr Nephrol 22:1062\u20131065","journal-title":"Pediatr Nephrol"},{"key":"6533_CR36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","volume":"21","author":"FP Wilson","year":"2014","unstructured":"Wilson FP, Berns JS (2014) Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis 21:18\u201326","journal-title":"Adv Chronic Kidney Dis"},{"key":"6533_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3\u201311","journal-title":"Br J Haematol"},{"key":"6533_CR38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.13403","volume":"169","author":"GL Jones","year":"2015","unstructured":"Jones GL, Will A, Jackson GH, Webb NJ, Rule S (2015) Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol 169:661\u2013671","journal-title":"Br J Haematol"},{"key":"6533_CR39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.emc.2021.04.007","volume":"39","author":"K Stephanos","year":"2021","unstructured":"Stephanos K, Dubbs SB (2021) Pediatric hematologic and oncologic emergencies. Emerg Med Clin North Am 39:555\u2013571","journal-title":"Emerg Med Clin North Am"},{"key":"6533_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/10428190903456959","volume":"51","author":"M Darmon","year":"2010","unstructured":"Darmon M, Guichard I, Vincent F, Schlemmer B, Azoulay E (2010) Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma 51:221\u2013227","journal-title":"Leuk Lymphoma"},{"key":"6533_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/nep.12806","volume":"22","author":"PS Garimella","year":"2017","unstructured":"Garimella PS, Balakrishnan P, Ammakkanavar NR, Patel S, Patel A, Konstantinidis I, Annapureddy N, Nadkarni GN (2017) Impact of dialysis requirement on outcomes in tumor lysis syndrome. Nephrology (Carlton) 22:85\u201388","journal-title":"Nephrology (Carlton)"},{"key":"6533_CR42","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29255","volume":"68","author":"K Flood","year":"2021","unstructured":"Flood K, Rozmus J, Skippen P, Matsell DG, Mammen C (2021) Fluid overload and acute kidney injury in children with tumor lysis syndrome. Pediatr Blood Cancer 68:e29255","journal-title":"Pediatr Blood Cancer"},{"key":"6533_CR43","doi-asserted-by":"crossref","unstructured":"Cheung WL, Hon KL, Fung CM, Leung AK (2020) Tumor lysis syndrome in childhood malignancies. Drugs Context 9","DOI":"10.7573\/dic.2019-8-2"},{"key":"6533_CR44","doi-asserted-by":"crossref","first-page":"1234677","DOI":"10.3389\/fonc.2023.1234677","volume":"13","author":"A Anderson","year":"2023","unstructured":"Anderson A, Shoulders L, James V, Ashcraft E, Cheng C, Ribeiro R, Elbahlawan L (2023) Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies. Front Oncol 13:1234677","journal-title":"Front Oncol"},{"key":"6533_CR45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00860936","volume":"9","author":"SL Saccente","year":"1995","unstructured":"Saccente SL, Kohaut EC, Berkow RL (1995) Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Pediatr Nephrol 9:569\u2013573","journal-title":"Pediatr Nephrol"},{"key":"6533_CR46","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/CCM.0000000000001826","volume":"44","author":"A Deep","year":"2016","unstructured":"Deep A, Stewart CE, Dhawan A, Douiri A (2016) Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med 44:1910\u20131919","journal-title":"Crit Care Med"},{"key":"6533_CR47","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1097\/PCC.0000000000000172","volume":"15","author":"L Chevret","year":"2014","unstructured":"Chevret L, Durand P, Lambert J, Essouri S, Balu L, Devictor D, Tissieres P (2014) High-volume hemofiltration in children with acute liver failure. Pediatr Crit Care Med 15:e300-305","journal-title":"Pediatr Crit Care Med"},{"key":"6533_CR48","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/liv.12369","volume":"34","author":"M Habib","year":"2014","unstructured":"Habib M, Roberts LN, Patel RK, Wendon J, Bernal W, Arya R (2014) Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int 34:672\u2013678","journal-title":"Liver Int"},{"key":"6533_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PCC.0000000000003371","volume":"25","author":"A Deep","year":"2024","unstructured":"Deep A, Alexander EC, Khatri A, Kumari N, Sudheendhra K, Patel P, Joarder A, Elghuwael I (2024) Epoprostenol (prostacyclin analog) as a sole anticoagulant in continuous renal replacement therapy for critically ill children with liver disease: single-center retrospective study, 2010\u20132019. Pediatr Crit Care Med 25:15\u201323","journal-title":"Pediatr Crit Care Med"},{"key":"6533_CR50","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00467-022-05502-8","volume":"37","author":"MJ Miyaji","year":"2022","unstructured":"Miyaji MJ, Ide K, Takashima K, Maeno M, Krallman KA, Lazear D, Goldstein SL (2022) Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy. Pediatr Nephrol 37:2733\u20132742","journal-title":"Pediatr Nephrol"},{"key":"6533_CR51","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","volume":"66","author":"J Wendon","year":"2017","unstructured":"Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Samuel D, Simpson KJ, Yaron I, Bernardi M (2017) EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 66:1047\u20131081","journal-title":"J Hepatol"},{"key":"6533_CR52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, Patriquin CJ, Pham HP, Sanchez AP, Schneiderman J, Witt V, Zantek ND, Dunbar NM (2023) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 38:77\u2013278","journal-title":"J Clin Apher"},{"key":"6533_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","volume":"64","author":"FS Larsen","year":"2016","unstructured":"Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, Triantafyllou E, Bernal W, Auzinger G, Shawcross D, Eefsen M, Bjerring PN, Clemmesen JO, Hockerstedt K, Frederiksen HJ, Hansen BA, Antoniades CG, Wendon J (2016) High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 64:69\u201378","journal-title":"J Hepatol"},{"key":"6533_CR54","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00467-020-04613-4","volume":"36","author":"BS Zoica","year":"2021","unstructured":"Zoica BS, Deep A (2021) Extracorporeal renal and liver support in pediatric acute liver failure. Pediatr Nephrol 36:1119\u20131128","journal-title":"Pediatr Nephrol"},{"key":"6533_CR55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00467-023-05937-7","volume":"39","author":"K Deville","year":"2023","unstructured":"Deville K, Charlton N, Askenazi D (2023) Use of extracorporeal therapies to treat life-threatening intoxications. Pediatr Nephrol 39:105\u2013113","journal-title":"Pediatr Nephrol"},{"key":"6533_CR56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1203\/00006450-197404000-00149","volume":"8","author":"G Levy","year":"1974","unstructured":"Levy G, Yaffe SJ (1974) Relationship between dose and apparent volume of distribution of salicyiate in children. Pediatr Res 8:365\u2013365","journal-title":"Pediatr Res"},{"key":"6533_CR57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.jrn.2011.10.011","volume":"22","author":"TW Meyer","year":"2012","unstructured":"Meyer TW (2012) The removal of protein-bound solutes by dialysis. J Ren Nutr 22:203\u2013206","journal-title":"J Ren Nutr"},{"key":"6533_CR58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/AAC.30.4.565","volume":"30","author":"MN Dudley","year":"1986","unstructured":"Dudley MN, Shyu W, Nightingale C, Quintiliani R (1986) Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans. Antimicrob Agents Chemother 30:565\u2013569","journal-title":"Antimicrob Agents Chemother"},{"key":"6533_CR59","doi-asserted-by":"crossref","unstructured":"Mirrakhimov AE, Barbaryan A, Gray A, Ayach T (2016) The role of renal replacement therapy in the management of pharmacologic poisonings. Int J Nephrol 2016:304329","DOI":"10.1155\/2016\/3047329"},{"key":"6533_CR60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/toxins12050317","volume":"12","author":"H Allawati","year":"2020","unstructured":"Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C (2020) A pharmacokinetic study comparing the clearance of vancomycin during haemodialysis using medium cut-off membrane (theranova) and high-flux membranes (revaclear). Toxins 12:317","journal-title":"Toxins"},{"key":"6533_CR61","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.2008.476","volume":"74","author":"PK Tyagi","year":"2008","unstructured":"Tyagi PK, Winchester JF, Feinfeld DA (2008) Extracorporeal removal of toxins. Kidney Int 74:1231\u20131233","journal-title":"Kidney Int"},{"key":"6533_CR62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215823","volume":"14","author":"L Weidhase","year":"2019","unstructured":"Weidhase L, Haussig E, Haussig S, Kaiser T, de Fallois J, Petros S (2019) Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: a prospective randomized controlled trial. PLoS One 14:e0215823","journal-title":"PLoS ONE"},{"key":"6533_CR63","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1345\/aph.19387","volume":"34","author":"SL Kane","year":"2000","unstructured":"Kane SL, Constantiner M, Staubus AE, Meinecke CD, Sedor JR (2000) High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 34:1146\u20131151","journal-title":"Ann Pharmacother"},{"key":"6533_CR64","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s00134-012-2501-8","volume":"38","author":"M Sikma","year":"2012","unstructured":"Sikma M, Van den Broek M, Meulenbelt J (2012) Increased unbound drug fraction in acute carbamazepine intoxication: suitability and effectiveness of high-flux haemodialysis. Intensive Care Med 38:916\u2013917","journal-title":"Intensive Care Med"},{"key":"6533_CR65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1592\/phco.30.1.111","volume":"30","author":"AM Vilay","year":"2010","unstructured":"Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ (2010) Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase. Pharmacotherapy 30:111","journal-title":"Pharmacotherapy"},{"key":"6533_CR66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5152\/TurkPediatriArs.2016.2335","volume":"51","author":"HS K\u0131ht\u0131r","year":"2016","unstructured":"K\u0131ht\u0131r HS, Y\u0131ld\u0131r\u0131m HM, Ye\u015filba\u015f O, Duramaz BB, \u015eevketo\u011flu E (2016) Single-pass albumin dialysis in a child aged six months with phenobarbital poisoning. Turk Pediatr Ars 51:228","journal-title":"Turk Pediatr Ars"},{"key":"6533_CR67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/hdi.12132","volume":"18","author":"YK Chung","year":"2014","unstructured":"Chung YK, Chang KY, Park HS, Kim MH, Lee KM, Lim TS, Kim HW (2014) Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow. Hemodial Int 18:551\u2013555","journal-title":"Hemodial Int"},{"key":"6533_CR68","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1034\/j.1399-6576.2003.00190.x","volume":"47","author":"AM Koivusalo","year":"2003","unstructured":"Koivusalo AM, Yildirim Y, Vakkuri A, Lindgren L, H\u00f6ckerstedt K, Isoniemi H (2003) Experience with albumin dialysis in five patients with severe overdoses of paracetamol. Acta Anaesthesiol Scand 47:1145\u20131150","journal-title":"Acta Anaesthesiol Scand"},{"key":"6533_CR69","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/ndt\/17.2.316","volume":"17","author":"CW McIntyre","year":"2002","unstructured":"McIntyre CW, Fluck RJ, Freeman JG, Lambie SH (2002) Use of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication. Nephrol Dial Transplant 17:316\u2013317","journal-title":"Nephrol Dial Transplant"},{"key":"6533_CR70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/15563650500516041","volume":"44","author":"N Pichon","year":"2006","unstructured":"Pichon N, Fran\u00e7ois B, Clavel M, Vignon P, Chevreuil C, Michel Gaulier J (2006) Albumin dialysis: a new therapeutic alternative for severe diltiazem intoxication. Clin Toxicol (Phila) 44:195\u2013196","journal-title":"Clin Toxicol (Phila)"},{"key":"6533_CR71","first-page":"189","volume":"8","author":"A Dobisova","year":"2021","unstructured":"Dobisova A, Vavrinec P, Vavrincova-Yaghi D, Gebhardtova A, Henning RH, Yaghi A (2021) Case report: enhanced diazepam elimination with the molecular adsorbents recirculating system (MARS) in severe autointoxication: a survival case report. Front Med (Lausanne) 8:189","journal-title":"Front Med (Lausanne)"},{"key":"6533_CR72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1478-3231.23.s.3.9.x","volume":"23","author":"A Covic","year":"2003","unstructured":"Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Volovat C, Dimitriu AG, Cristogel F, Bizo A (2003) Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 23:21\u201327","journal-title":"Liver Int"},{"key":"6533_CR73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1034\/j.1600-0676.2002.00016.x","volume":"22","author":"S Prokurat","year":"2002","unstructured":"Prokurat S, Grenda R, Lipowski D, Kalici\u0144ski P, Migdal M, Prokurat S, Grenda R, Lipowski D, Kalici\u0144ski P, Migdal M (2002) MARS procedure as a bridge to combined liver\u2013kidney transplantation in severe chromium\u2013copper acute intoxication: a paediatric case report. Liver 22:76\u201377","journal-title":"Liver"},{"key":"6533_CR74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1528-1157.2003.31402.x","volume":"44","author":"S Sen","year":"2003","unstructured":"Sen S, Ratnaraj N, Davies NA, Mookerjee RP, Cooper CE, Patsalos PN, Williams R, Jalan R (2003) Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia 44:265\u2013267","journal-title":"Epilepsia"},{"key":"6533_CR75","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ndt\/gfl640","volume":"22","author":"S Korsheed","year":"2007","unstructured":"Korsheed S, Selby NM, Fluck RJ (2007) Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS). Nephrol Dial Transplant 22:969\u2013970","journal-title":"Nephrol Dial Transplant"},{"key":"6533_CR76","first-page":"22","volume":"27","author":"KD Soni","year":"2023","unstructured":"Soni KD, Singh A, Tyagi A, Singh Y, Aggarwal R, Trikha A (2023) Risk factors and outcomes of post-traumatic acute kidney injury requiring renal replacement therapy: a case-control study. Indian J Crit Care Med 27:22\u201325","journal-title":"Indian J Crit Care Med"},{"key":"6533_CR77","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/MCC.0000000000000463","volume":"23","author":"A Harrois","year":"2017","unstructured":"Harrois A, Libert N, Duranteau J (2017) Acute kidney injury in trauma patients. Curr Opin Crit Care 23:447\u2013456","journal-title":"Curr Opin Crit Care"},{"key":"6533_CR78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s13054-018-2265-9","volume":"22","author":"A Harrois","year":"2018","unstructured":"Harrois A, Soyer B, Gauss T, Hamada S, Raux M, Duranteau J (2018) Prevalence and risk factors for acute kidney injury among trauma patients: a multicenter cohort study. Crit Care 22:344","journal-title":"Crit Care"},{"key":"6533_CR79","volume":"10","author":"M Yousefifard","year":"2022","unstructured":"Yousefifard M, Toloui A, Forouzannia SA, Ataei N, Hossein H, Zareie Shab Khaneh A, Karimi Ghahfarokhi M, Jones ME, Hosseini M (2022) Prevalence and mortality of post-traumatic acute kidney injury in children; a systematic review and meta-analysis. Arch Acad Emerg Med 10:e89","journal-title":"Arch Acad Emerg Med"},{"key":"6533_CR80","volume":"2014","author":"S Beitland","year":"2014","unstructured":"Beitland S, Os I, Sunde K (2014) Primary injuries and secondary organ failures in trauma patients with acute kidney injury treated with continuous renal replacement therapy. Scientifica (Cairo) 2014:235215","journal-title":"Scientifica (Cairo)"},{"key":"6533_CR81","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1399-6576.2010.02253.x","volume":"54","author":"S Beitland","year":"2010","unstructured":"Beitland S, Moen H, Os I (2010) Acute kidney injury with renal replacement therapy in trauma patients. Acta Anaesthesiol Scand 54:833\u2013840","journal-title":"Acta Anaesthesiol Scand"},{"key":"6533_CR82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211001","volume":"14","author":"ZB Perkins","year":"2019","unstructured":"Perkins ZB, Captur G, Bird R, Gleeson L, Singer B, O\u2019Brien B (2019) Trauma induced acute kidney injury. PLoS One 14:e0211001","journal-title":"PLoS ONE"},{"key":"6533_CR83","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/cc10061","volume":"15","author":"CJ Karvellas","year":"2011","unstructured":"Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, Bagshaw SM (2011) A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 15:R72","journal-title":"Crit Care"},{"key":"6533_CR84","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s001340050956","volume":"25","author":"LG Gettings","year":"1999","unstructured":"Gettings LG, Reynolds HN, Scalea T (1999) Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 25:805\u2013813","journal-title":"Intensive Care Med"},{"key":"6533_CR85","first-page":"1743","volume":"44","author":"X Li","year":"2022","unstructured":"Li X, Bai M, Yu Y, Ma F, Zhao L, Li Y, Wu H, Zhou L, Sun S (2022) Earlier continuous renal replacement therapy is associated with reduced mortality in rhabdomyolysis patients. Ren Fail 44:1743\u20131753","journal-title":"Ren Fail"},{"key":"6533_CR86","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1159\/000521923","volume":"51","author":"A Jerman","year":"2022","unstructured":"Jerman A, Andonova M, Persic V, Gubensek J (2022) extracorporeal removal of myoglobin in patients with rhabdomyolysis and acute kidney injury: comparison of high and medium cut-off membrane and an adsorber cartridge. Blood Purif 51:907\u2013911","journal-title":"Blood Purif"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06533-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T13:48:51Z","timestamp":1741268931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06533-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6533"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06533-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For full disclosure, we provide here an additional list of other author\u2019s commitments and funding sources that are not directly related to this study: David J Askenazi is a consultant for Baxter, Nuwellis, Seastar, Bioporto, and Abbott. Over the last 24\u00a0months, his institution has received funding for education and research that is not related to this project from NIH, Baxter, Nuwellis, Bioporto, Portero, Leadiant, and Seastar. He has financial interests in patent\/innovations in kidney support therapies and urine collection devices. He is the Founder and Chief Scientific Officer of Zorro-Flow Inc. Jolyn Morgan is a consultant for Mozarc Medical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}